Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00417742
Other study ID # 0728
Secondary ID AHRQ Grant No.:
Status Completed
Phase N/A
First received January 2, 2007
Last updated August 20, 2014
Start date June 2002
Est. completion date December 2004

Study information

Verified date January 2007
Source Duke University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

PROJECT CHEER is a randomized controlled trial designed to test the effectiveness of a comprehensive focused approach to headache care. Three institutions are collaborating in this trial by establishing special Headache Programs that can provide individualized treatment and follow-up: Duke University Medical Center in Durham, NC; Thomas Jefferson University in Philadelphia, PA; and Kaiser Permanente in San Diego, CA. Support and oversight are provided by the U.S. Agency for Healthcare Research and Quality.

HEADACHE sufferers age 18 and over whose headaches interfere with their ability to work, study or enjoy life are eligible for this trial. Half of the enrolled individuals will be selected at random to receive care in the Headache Program and half will continue to receive care as usual from their primary care providers.

EVALUATION is an important part of this project. Every participant completes a screening interview and survey at the time of enrollment. The initial evaluation will provide an accurate diagnosis of headache type(s). The results of this evaluation will be reported to the primary care provider and may help to provide usual care. Subjects assigned to the Headache Program are further evaluated by the program manager in consultation with a headache specialist.

EDUCATION in headache care is provided to participants assigned to the Headache Program.

The classes include suggestions on diet and lifestyle as well as a review of medication use.

Note: The above is excerpted from the flyer we distributed to recruit patients to the trial.


Description:

The purpose of this study is to determine whether headache management programs should be promoted as a preferred strategy for managing patients with chronic disabling headache.

Chronic headache affects between 6% and 17% of the population and is associated with significant numbers of days lost from work and reduced quality of life, as well as disproportionate use of medical resources. Current treatment is sub-optimal, with patients often not adequately diagnosed and/or not receiving appropriate preventive and acute pharmacologic therapy or behavioral modification. As a result, chronic headache is associated with sub-optimal quality of care, high patient dissatisfaction as well as high cost to individuals, insurers, and society.

The specific hypothesis of this study is that a properly designed headache management program (HMP) will reduce headache-related disability, improve process of care, and reduce management costs for patients with chronic headache. The format is a randomized controlled trial in which a patient population participating in a HMP will be compared with a corresponding patient population receiving usual care. A pilot study1 has determined the components of an optimal HMP and the effectiveness of a prototype of this service with a limited number of patients at a Kaiser Permanente facility in Santa Rosa, California.


Recruitment information / eligibility

Status Completed
Enrollment 828
Est. completion date December 2004
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 21 Years and older
Eligibility Inclusion Criteria:

- age 21 or over

- have chronic headache thought to be of tension-type, migraine or mixed etiology

- intend to continue headache care at their current location for the next six months

- MIDAS score >5

Exclusion Criteria:

- Under age 21

- Currently seeing a neurologist for headache care

- Currently being seen in a Headache Clinic

- MIDAS score <5

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Service delivery through a Headache Management Program


Locations

Country Name City State
United States Duke University Medical Center Durham North Carolina
United States Thomas Jefferson University Philadelphia Pennsylvania
United States Kaiser Permanente San Diego California

Sponsors (4)

Lead Sponsor Collaborator
Duke University Agency for Healthcare Research and Quality (AHRQ), Innovative Medical, Thomas Jefferson University

Country where clinical trial is conducted

United States, 

References & Publications (1)

Harpole LH, Samsa GP, Jurgelski AE, Shipley JL, Bernstein A, Matchar DB. Headache management program improves outcome for chronic headache sufferers. Cephalalgia 1999;19:1-8

Outcome

Type Measure Description Time frame Safety issue
Primary MIDAS, simple and accurate five-question survey that measures days lost to headache disability during the last 3 months and also headache pain on a 10-point scale.
Primary The measure is taken by telephone at the screening interview and by mailed survey at basel
Secondary CATI headache diagnostic survey is administered by telephone at the screening interview to obtain a diagnosis of headache type.
Secondary SF-36 Quality of Life Survey is administered by mailed survey at baseline and at 6 and 12 months
Secondary Health Care Utilization Measures will include self-report by patients on the mailed surveys at baseline and at 3, 6 and 12 months.
Secondary Patients are asked about their use of outpatient, inpatient and emergency room services, as well as use of alternative therapies (e.g., accupuncture, massage therpay, herbalists) and prescription and nonprescription drugs.
Secondary Patient reports will be validated by administrative utilization data and by a limited chart review at each site.
See also
  Status Clinical Trial Phase
Recruiting NCT05414513 - The Turkish Fear of Pain Questionnaire
Not yet recruiting NCT06077747 - Lumbar Vein Embolization for Chronic Headaches With Nutcracker Physiology N/A
Completed NCT02514148 - Biobehavioral Physical Therapy Strategies Based on Therapeutic Exercise Applied to Chronic Migraine Patients N/A
Not yet recruiting NCT00897780 - Combined Biofeedback With Virtual Reality in the Treatment of Pediatric Headache N/A
Completed NCT00228267 - Propofol Injection for Daily Headache Phase 2
Completed NCT02684916 - Chiropractic Treatment for Headache Among Children Aged 7-14 N/A
Not yet recruiting NCT05613582 - The Effectiveness of Transcranial Direct Current Stimulation as Adjunctive Treatment for Chronic Daily Headache in Systemic Lupus Erythematosus N/A
Completed NCT02440997 - A Preliminary Investigation of the Efficacy of Aromatherapy in Reducing Discomfort in Youth With Chronic Headache N/A
Completed NCT01314768 - Brief Intervention for Medication Overuse Headache N/A
Enrolling by invitation NCT06127888 - Impementation of the Exercise Recommendations for the Treatment of Primary Headaches: A Qualitative Approach to the Headache Units in Catalonia
Terminated NCT02141568 - Effectiveness of Mind-Body Interventions for Frequent Attendees Suffering From Medically Unexplained Symptoms (MUS) N/A
Recruiting NCT04195685 - Neurofeedback Impact on Veterans With mTBI N/A
Completed NCT03080779 - Long Term Outcomes After Accidental Dural Puncture ADP Study
Not yet recruiting NCT00286923 - Does Topiramate Adjust the Excitability of the Brain in Migraine Sufferers? N/A
Completed NCT04696627 - Long-term Complications of Unintentional Dural Puncture During Labour Epidurals and Epidural Blood Patch.
Recruiting NCT02302027 - Feasibility Study of Normobaric Oxygen Delivered by a High Flow Concentrator in the Treatment of Chronic Headache N/A
Completed NCT03503734 - Integrated Care for Migraine and Chronic Tension-type Headaches
Recruiting NCT02753933 - Direct Access to MRI and Neurology Referrals for the Management of Patients With Chronic Headache. N/A